Company profile: Precision NanoSystems
1.1 - Company Overview
Company description
- Provider of tools and processes for developing and manufacturing nanoparticles for medicines and medical research, offering the NanoAssemblr benchtop instrument for nanoparticle prototyping and for developing nanoparticle-based drugs delivering RNA, small-molecule, and protein therapeutics, and Neuro9Kit to study gene function in neurons and glia cells.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Precision NanoSystems
ALPCO
HQ: United States
Website
- Description: Provider of testing solutions for scientists and healthcare professionals, delivering molecular and immunodiagnostic assays across gastroenterology, allergy/infectious disease, diabetes and obesity, bone metabolism, and antibodies/antigens. Offerings include fecal calprotectin and pancreatic elastase assays, IgE allergy testing, and multiplex PCR detecting CT/NG/MG to inform research and quality of care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ALPCO company profile →
OmniAb
HQ: United States
Website
- Description: Provider of antibody discovery technologies for next-generation therapeutics, offering the OmniAb Discovery Platform with diverse antibody repertoires and high-throughput screening via proprietary transgenic animals. Platforms include OmniRat, OmniMouse, and OmniChicken for fully human antibodies, and OmniFlic and OmniClic for bispecific antibodies using a common light chain.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmniAb company profile →
Amaryllis Nucleics
HQ: United States
Website
- Description: Provider of proprietary RNA sequencing methods and end-to-end solutions delivering shorter turnaround from RNA to library prep and complete data analysis at a lower cost per sample compared to whole transcriptome sequencing approaches for RNASeq; Bay Area-based start-up.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amaryllis Nucleics company profile →
Akoya Biosciences
HQ: United States
Website
- Description: Provider of end-to-end spatial biology solutions for high-parameter tissue analysis from biomarker discovery through clinical and translational research, enabling more precise therapies in immuno-oncology and drug development; offerings include PhenoCycler for spatial phenotyping at unprecedented speeds and PhenoImager for comprehensive tissue analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akoya Biosciences company profile →
Delphi Genetics
HQ: Belgium
Website
- Description: Provider of plasmid DNA and genetic engineering services, developing customized GMP plasmid DNA manufacturing solutions to support viral and non-viral gene therapy programs, based on unique technologies including patented STABY® technology without antibiotic resistance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Delphi Genetics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Precision NanoSystems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Precision NanoSystems
2.2 - Growth funds investing in similar companies to Precision NanoSystems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Precision NanoSystems
4.2 - Public trading comparable groups for Precision NanoSystems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →